NM_006214.4(PHYH):c.303G>T (p.Met101Ile) AND not provided

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jul 25, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV002622291.1

Allele description [Variation Report for NM_006214.4(PHYH):c.303G>T (p.Met101Ile)]

NM_006214.4(PHYH):c.303G>T (p.Met101Ile)

Gene:

PHYH:phytanoyl-CoA 2-hydroxylase [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

10p13

Genomic location:

Preferred name:

NM_006214.4(PHYH):c.303G>T (p.Met101Ile)

HGVS:

NC_000010.11:g.13294539C>A
NG_012862.1:g.10592G>T
NM_001037537.2:c.3G>T
NM_001323080.2:c.3G>T
NM_001323082.2:c.303G>T
NM_001323083.2:c.303G>T
NM_001323084.2:c.3G>T
NM_006214.4:c.303G>TMANE SELECT
NP_001032626.1:p.Met1Ile
NP_001310009.1:p.Met1Ile
NP_001310011.1:p.Met101Ile
NP_001310012.1:p.Met101Ile
NP_001310013.1:p.Met1Ile
NP_006205.1:p.Met101Ile
NC_000010.10:g.13336539C>A

Protein change:

M101I

Molecular consequence:

NM_001037537.2:c.3G>T - initiator_codon_variant - [Sequence Ontology: SO:0001582]
NM_001323080.2:c.3G>T - initiator_codon_variant - [Sequence Ontology: SO:0001582]
NM_001323084.2:c.3G>T - initiator_codon_variant - [Sequence Ontology: SO:0001582]
NM_001037537.2:c.3G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001323080.2:c.3G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001323082.2:c.303G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001323083.2:c.303G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001323084.2:c.3G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_006214.4:c.303G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: CN517202

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002977249	Invitae	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Jul 25, 2022)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002977249

Invitae

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Jul 25, 2022)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Invitae, SCV002977249.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This sequence change replaces methionine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 101 of the PHYH protein (p.Met101Ile). This variant is present in population databases (no rsID available, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with PHYH-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 3, 2023

ClinVar

Relating variation to medicine